CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-12 | AFEYAN NOUBAR Director | Sale 10b5-1 | −6,397 | $147.55 | $944K | 2,317,216 |
| 2024-06-12 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,601 | $148.61 | $238K | 2,315,615 |
| 2024-06-12 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,400 | $149.39 | $209K | 2,314,215 |
| 2024-06-12 | AFEYAN NOUBAR Director | Sale 10b5-1 | −200 | $150.24 | $30K | 2,314,015 |
| 2024-06-11 | AFEYAN NOUBAR Director | Sale | −163,649 | $148.29 | $24.3M | 7,937,145 |
| 2024-06-11 | AFEYAN NOUBAR Director | Sale | −31,531 | $148.29 | $4.7M | 1,529,789 |
| 2024-06-11 | AFEYAN NOUBAR Director | Sale | −6,420 | $149.40 | $959K | 7,930,725 |
| 2024-06-11 | AFEYAN NOUBAR Director | Sale | −1,232 | $149.40 | $184K | 1,528,557 |
| 2024-06-10 | Klinger Shannon Thyme Chief Legal Officer | Sale 10b5-1 | −5,178 | $148.09 | $767K | 15,947 |
| 2024-06-07 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +1,139 | 12,017 | ||
| 2024-06-07 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion 10b5-1 | +9,108 | 21,125 | ||
| 2024-06-07 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,139 | 4,555 | ||
| 2024-06-07 | Klinger Shannon Thyme Chief Legal Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −9,108 | 0 | ||
| 2024-06-05 | AFEYAN NOUBAR Director | Sale 10b5-1 | −900 | $145.91 | $131K | 1,961,031 |
| 2024-06-05 | AFEYAN NOUBAR Director | Sale 10b5-1 | −700 | $147.78 | $103K | 1,960,331 |
| 2024-06-05 | AFEYAN NOUBAR Director | Sale 10b5-1 | −1,800 | $148.57 | $267K | 1,958,531 |
| 2024-06-05 | AFEYAN NOUBAR Director | Sale 10b5-1 | −300 | $149.35 | $45K | 1,958,231 |
| 2024-06-05 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,840 | $151.07 | $429K | 1,955,391 |
| 2024-06-05 | AFEYAN NOUBAR Director | Sale 10b5-1 | −3,902 | $151.76 | $592K | 1,951,489 |
| 2024-06-05 | AFEYAN NOUBAR Director | Sale 10b5-1 | −2,437 | $152.90 | $373K | 1,949,052 |
Page 27 of 38 · 743 trades